Generative Adversarial Networks in Medical Imaging: Recent Advances and Future Prospects

Preview this chapter:

Generative Adversarial Networks in Medical Imaging: Recent Advances and Future Prospects, Page 1 of 1

< Previous page | Next page > /docserver/preview/fulltext/9789815274134/chapter-9-1.gif

Generative Adversarial Networks (GANs) represent a significant breakthrough in the realms of machine learning and deep learning, providing novel solutions to the constraints of conventional generative models. This article explores the transformative uses of GANs in the domain of medical imaging, specifically focusing on super-resolution applications in Magnetic Resonance Imaging (MRI), generation of synthetic images for skin lesion categorization, and overall improvement in diagnostic accuracy. The fundamental structure of GANs, comprising a Generator and a Discriminator engaged in adversarial training, facilitates the creation of high-fidelity synthetic medical images. These developments play a crucial role in fortifying machine learning models through the amalgamation of synthetic data with authentic medical datasets, thereby enhancing the precision of diagnostic algorithms and the standard of healthcare provision. Notable innovations encompass the Fused Attentive GAN (FAGAN) for enhanced MRI clarity and the employment of Pix2Pix GANs for precise brain imaging. Moreover, GAN-centric techniques for the classification of skin lesions, leveraging the ISIC dataset, have showcased substantial enhancements in diagnostic efficacy. Despite their considerable potential, the incorporation of GANs in the healthcare domain necessitates careful navigation of key ethical considerations like patient confidentiality and bias alleviation. It is vital to underscore the need for robust assessment metrics beyond visual accuracy to ensure the clinical applicability of GANgenerated data. This manuscript underscores the continual progressions and the imperative requirement for ethical governance in the utilization of GANs, which hold the potential to transform personalized healthcare, expedite pharmaceutical discoveries, and enrich telemedicine, representing a significant stride forward in medical research and patient welfare.